WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for ProQR Therapeutics N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-05-09 3:31 pm Sale | 2022-04-29 | 13G | ProQR Therapeutics N.V. PRQR | WELLINGTON MANAGEMENT GROUP LLP | 0 0.000% | -4,017,760 (Position Closed) | Filing |
| 2022-02-04 09:12 am Purchase | 2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR | WELLINGTON MANAGEMENT GROUP LLP | 4,017,760 5.650% | 561,995 (+16.26%) | Filing |
| 2021-02-03 1:22 pm Sale | 2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR | WELLINGTON MANAGEMENT GROUP LLP | 3,455,765 6.390% | -2,039,363 (-37.11%) | Filing |